Diabetic Nephropathy

A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases. Read More

Vanderbilt researchers are looking to mRNA populations in podocytes — kidney cells that help filter blood — to help identify potential targets for treating diabetic kidney disease. Read More

Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication. Read More

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies. Read More

Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy. Read More

Gautam Bhave, M.D., Ph.D., assistant professor of Medicine, is receiving the Burroughs Wellcome Fund 2013 Career Award for Medical Scientists (CAMS) for his research on the role of peridoxasin and protein halogenation in diabetic nephropathy. Read More

Vanderbilt University Medical Center investigators have demonstrated that dopamine produced outside the brain – in the kidneys – is important for renal function, blood pressure regulation and life span. Read More